SOM Biotech will attend the Eyeforpharma Barcelona event that will be hosted online due to the impact of COVID-19, between March 31st and April 2nd 2020.
Maria Zimina – Business Development Manager – underlines: “We look forward to having the opportunity to share and discuss with potential business partners and specialized investors the progress made with our pipeline and R&D activities, as well as the unique characteristics of our AI-based proprietary technology – SOMAIPRO-, which allows us to identify effective drugs with a very high likelihood of success. Our validated technology is suited to be applied for any therapeutic area and for new chemical entities. Therefore, SOMAIPRO is a clear value creation asset not only for SOM Biotech, but also for all business partners that decide to join us to achieve major milestones in the development of innovative and effective treatments to tackle some of the most acute diseases.”
Eyeforpharma, one of the leading providers of ideas and insights for the pharmaceutical sector globally, organizes conferences as “hubs” for senior-level pharma executives, patient groups and other health stakeholders to exchange ideas and observe shifting trends and practices. Eyeforpharma provides commentary, events, reports, and other expert-driven content across multiple channels to help to understand the pharma industry.
If you want to arrange an online meeting with SOM Biotech, you can contact us.